Metagenomi (NASDAQ: MGX) reported Q2 2024 earnings per share (EPS) of -$0.29, up 92.41% year over year. Total Metagenomi earnings for the quarter were -$10.74 million. In the same quarter last year, Metagenomi's earnings per share (EPS) was -$3.82.
As of Q3 2024, Metagenomi's earnings has grown year over year. Metagenomi's earnings in the past year totalled N/A.
What was MGX's revenue last quarter?
Metagenomi (NASDAQ: MGX) reported Q2 2024 revenue of $20.01 million up 76.48% year over year. In the same quarter last year, Metagenomi's revenue was $11.34 million.
What was MGX's revenue growth in the past year?
As of Q3 2024, Metagenomi's revenue has grown null year over year. Metagenomi's revenue in the past year totalled N/A.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.